Brief: Faes Farma Sees Growth Of 5.5% For Net Sales In 2023 Versus 2022
29/03/2023 10:49
March 29 (Reuters) - Faes Farma SA FAE.MC :
* SEES GROWTH OF 5.5% FOR NET SALES IN 2023 VERSUS 2022
* SEES 2023 EBITDA BEFORE R+D+I GROWTH AT AROUND 4% VERSUS
2022
* SEES 2023 EBITDA BEFORE R+D+I AT BETWEEN 138-142 MILLION
EUROS
Source text for Eikon: ID:nCNM3sfGBG
Further company coverage: FAE.MC
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))